Anne-Mieke Vandamme
AuthID: R-000-Q27
281
TÃTULO: A combination of poor adherence and a low baseline susceptibility score is highly predictive for HAART failure
AUTORES: Van Vaerenbergh, K; De Geest, S; Derdelinckx, I; Bobbaers, H; Carbonez, A; Deschamps, A; De Graeve, V; De Saar, V; Ceunen, H; De Smet, K; Maes, B; Peetermans, W; Schrooten, Y; Desmyter, J; De Clercq, E; Van Ranst, M; Van Wijngaerden, E; Vandamme, AM;
PUBLICAÇÃO: 2002, FONTE: Antiviral Chemistry and Chemotherapy, VOLUME: 13, NÚMERO: 4
AUTORES: Van Vaerenbergh, K; De Geest, S; Derdelinckx, I; Bobbaers, H; Carbonez, A; Deschamps, A; De Graeve, V; De Saar, V; Ceunen, H; De Smet, K; Maes, B; Peetermans, W; Schrooten, Y; Desmyter, J; De Clercq, E; Van Ranst, M; Van Wijngaerden, E; Vandamme, AM;
PUBLICAÇÃO: 2002, FONTE: Antiviral Chemistry and Chemotherapy, VOLUME: 13, NÚMERO: 4
INDEXADO EM: 
Scopus
Scopus NO MEU: 
ORCID
ORCID282
TÃTULO: env chimeric virus technology for evaluating human immunodeficiency virus susceptibility to entry inhibitors
AUTORES: Fikkert, V; Cherepanov, P; van Laethem, K; Hantson, A; Van Remoortel, B; Pannecouque, C; De Clercq, E; Debyser, Z; Vandamme, AM; Witvrouw, M;
PUBLICAÇÃO: 2002, FONTE: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, VOLUME: 46, NÚMERO: 12
AUTORES: Fikkert, V; Cherepanov, P; van Laethem, K; Hantson, A; Van Remoortel, B; Pannecouque, C; De Clercq, E; Debyser, Z; Vandamme, AM; Witvrouw, M;
PUBLICAÇÃO: 2002, FONTE: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, VOLUME: 46, NÚMERO: 12
NO MEU: ORCID | 
ResearcherID
ORCID | ResearcherID283
TÃTULO: Preface - Virus evolution and molecular epidemiology Full Text
AUTORES: Vandamme, AM;
PUBLICAÇÃO: 2002, FONTE: VIRUS RESEARCH, VOLUME: 85, NÚMERO: 1
AUTORES: Vandamme, AM;
PUBLICAÇÃO: 2002, FONTE: VIRUS RESEARCH, VOLUME: 85, NÚMERO: 1
NO MEU: ORCID | ResearcherID
ORCID | ResearcherID284
TÃTULO: Phylogenetic classification of TT virus groups based on the N22 region is unreliable Full Text
AUTORES: Lemey, P; Salemi, M; Bassit, L; Vandamme, AM;
PUBLICAÇÃO: 2002, FONTE: VIRUS RESEARCH, VOLUME: 85, NÚMERO: 1
AUTORES: Lemey, P; Salemi, M; Bassit, L; Vandamme, AM;
PUBLICAÇÃO: 2002, FONTE: VIRUS RESEARCH, VOLUME: 85, NÚMERO: 1
NO MEU: ORCID | ResearcherID
ORCID | ResearcherID285
TÃTULO: Prevalence and origin of HIV-1 group M subtypes among patients attending a Belgian hospital in 1999 Full Text
AUTORES: Snoeck, J; Van Dooren, S; Van Laethem, K; Derdelinckx, I; Van Wijngaerden, E; De Clercq, E; Vandamme, AM;
PUBLICAÇÃO: 2002, FONTE: VIRUS RESEARCH, VOLUME: 85, NÚMERO: 1
AUTORES: Snoeck, J; Van Dooren, S; Van Laethem, K; Derdelinckx, I; Van Wijngaerden, E; De Clercq, E; Vandamme, AM;
PUBLICAÇÃO: 2002, FONTE: VIRUS RESEARCH, VOLUME: 85, NÚMERO: 1
NO MEU: ORCID | ResearcherID
ORCID | ResearcherID286
TÃTULO: A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export
AUTORES: Daelemans, D; Afonina, E; Nilsson, J; Werner, G; Kjems, J; De Clercq, E; Pavlakis, GN; Vandamme, AM;
PUBLICAÇÃO: 2002, FONTE: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, VOLUME: 99, NÚMERO: 22
AUTORES: Daelemans, D; Afonina, E; Nilsson, J; Werner, G; Kjems, J; De Clercq, E; Pavlakis, GN; Vandamme, AM;
PUBLICAÇÃO: 2002, FONTE: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, VOLUME: 99, NÚMERO: 22
NO MEU: ORCID | ResearcherID
ORCID | ResearcherID287
TÃTULO: The drug resistance profile of tenofovir: a story of resistance and resensitization
AUTORES: Wolf, K; Walter, H; Schnell, T; Keulen, W; Beerenwinkel, N; Selbig, J; Vandamme, AM; Korn, K; Schmidt, B;
PUBLICAÇÃO: 2002, FONTE: ANTIVIRAL THERAPY, VOLUME: 7
AUTORES: Wolf, K; Walter, H; Schnell, T; Keulen, W; Beerenwinkel, N; Selbig, J; Vandamme, AM; Korn, K; Schmidt, B;
PUBLICAÇÃO: 2002, FONTE: ANTIVIRAL THERAPY, VOLUME: 7
INDEXADO EM: WOS
WOS NO MEU: ORCID | ResearcherID
ORCID | ResearcherID288
TÃTULO: Determination of the optimal cut-offs for predicting the phenotype of nine different HIV drug-resistance algorithms
AUTORES: Zeitler, N; Schmidt, B; Korn, K; Keulen, W; Boucher, CAB; Beerenwinkel, N; Selbig, J; Vandamme, AM; Winslow, DL; Shafer, R; Schapiro, JM; Boulme, R; Schmit, JC; Walter, H;
PUBLICAÇÃO: 2002, FONTE: ANTIVIRAL THERAPY, VOLUME: 7
AUTORES: Zeitler, N; Schmidt, B; Korn, K; Keulen, W; Boucher, CAB; Beerenwinkel, N; Selbig, J; Vandamme, AM; Winslow, DL; Shafer, R; Schapiro, JM; Boulme, R; Schmit, JC; Walter, H;
PUBLICAÇÃO: 2002, FONTE: ANTIVIRAL THERAPY, VOLUME: 7
INDEXADO EM: WOS
WOS NO MEU: ORCID | ResearcherID
ORCID | ResearcherID289
TÃTULO: Drug resistance among therapy-naive HIV-infected patients studied by sequencing and VERSANT (TM) HIV-1 resistance assays (LiPA) has limited impact on treatment response.
AUTORES: Derdelinckx, I; Van Laethem, K; Maes, B; Schrooten, Y; Dewit, S; Florence, E; Fransen, K; Ribas, SG; Marissens, D; Moutschen, M; Van Wijngaerden, E; Vaira, D; Zissis, G; Van Ranst, M; Vandamme, AM;
PUBLICAÇÃO: 2002, FONTE: ANTIVIRAL THERAPY, VOLUME: 7
AUTORES: Derdelinckx, I; Van Laethem, K; Maes, B; Schrooten, Y; Dewit, S; Florence, E; Fransen, K; Ribas, SG; Marissens, D; Moutschen, M; Van Wijngaerden, E; Vaira, D; Zissis, G; Van Ranst, M; Vandamme, AM;
PUBLICAÇÃO: 2002, FONTE: ANTIVIRAL THERAPY, VOLUME: 7
INDEXADO EM: WOS
WOS NO MEU: ORCID | ResearcherID
ORCID | ResearcherID290
TÃTULO: Influence of subtype and treatment on genetic profiles of HIV-1 reverse transcriptase and protease: do they act independently in predicting position-specific mutation probabilities in non-subtype B sequences?
AUTORES: Kantor, R; Katzenstein, D; Gonzales, M; Sirivichayakul, S; Cane, P; Pillay, C; Snoeck, J; Grossman, Z; Vandamme, AM; Morris, L; Pillay, D; Phanuphak, P; Schapiro, JM; Shafer, RW;
PUBLICAÇÃO: 2002, FONTE: ANTIVIRAL THERAPY, VOLUME: 7
AUTORES: Kantor, R; Katzenstein, D; Gonzales, M; Sirivichayakul, S; Cane, P; Pillay, C; Snoeck, J; Grossman, Z; Vandamme, AM; Morris, L; Pillay, D; Phanuphak, P; Schapiro, JM; Shafer, RW;
PUBLICAÇÃO: 2002, FONTE: ANTIVIRAL THERAPY, VOLUME: 7
INDEXADO EM: WOS
WOS NO MEU: ORCID | ResearcherID
ORCID | ResearcherID